Chemokine programming dendritic cell antigen response: part II - programming antigen presentation to T lymphocytes by partially maintaining immature dendritic cell phenotype

X F Zhou, B Liu, X H Yu. Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccineJ Control Release. 2007.

K Birkholz, M Schwenkert, C Kellner. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentationBlood. 2010.

A Bandyopadhyay, R L Fine, S Demento, L K Bockenstedt, T M Fahmy. The impact of nanoparticle ligand density on dendritic-cell targeted vaccinesBiomaterials. 2011.

I A Khalil, K Kogure, H Akita, H Harashima. Uptake pathways and subsequent intracellular trafficking in nonviral gene deliveryPharmacol Rev. 2006.

A Heit, D H Busch, H Wagner, F Schmitz. Vaccine protocols for enhanced immunogenicity of exogenous antigensInt J Med Microbiol. 2008.

J A Hubbell, S N Thomas, M A Swartz. Materials engineering for immunomodulationNature. 2009.

O A Ali, N Huebsch, L Cao, G Dranoff, D J Mooney. Infection-mimicking materials to program dendritic cells in situNat Mater. 2009.

O A Ali, D J Mooney. Sustained GM-CSF and PEI condensed pDNA presentation increases the level and duration of gene expression in dendritic cellsJ Control Release. 2008.

P J Tacken, Ijm De Vries, R Torensma, C G Figdor. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingNat Rev Immunol. 2007.

L Piemonti, P Monti, P Allavena, B E Leone, A Caputo, Di Carlo, V. Glucocorticoids increase the endocytic activity of human dendritic cellsInt Immunol. 1999.

Y Yanagawa, K Onoe. CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activitiesBlood. 2003.

M B Lutz, N Kukutsch, Alj Ogilvie, S Rossner, F Koch, N Romani, G Schuler. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrowJ Immunol Methods. 1999.

N Iijima, Y Yanagawa, J M Clingan, K Onoe. CCR7-mediated c-Jun N-terminal kinase activation regulates cell migration in mature dendritic cellsInt Immunol. 2005.

J G Quatromoni, L F Morris, T R Donahue, Y Wang, W Mcbride, T Chatila, J S Economou. T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3J Hematol Oncol. 2011.

A A Filatenkov, E L Jacovetty, U B Fischer, J M Curtsinger, M F Mescher, E Ingulli. CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection and avoidance of toleranceJ Immunol. 2005.

B Priyadharshini, D L Greiner, M A Brehm. T-cell activation and transplantation toleranceTransplant Rev. 2012.

K J Lafferty, J Woolnough. The origin and mechanism of the allograft reactionImmunol Rev. 1977.

S Jaleco, L Swainson, V Dardalhon, M Burjanadze, S Kinet, N Taylor. Homeostasis of naive and memory CD4 + T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosisJ Immunol. 2003.

D K Dalton, L Haynes, C Q Chu, S L Swain, S Wittmer. Interferon c eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cellsJ Exp Med. 2000.

V P Badovinac, A R Tvinnereim, J T Harty. Regulation of antigen-specific CD8 + T cell homeostasis by perforin and interferon-cScience. 2000.

M Lenardo, K M Chan, F Hornung, H Mcfarland, R Siegel, J Wang, L Zheng. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environmentAnnu Rev Immunol. 1999.

L Van Parijs, A K Abbas. Homeostasis and self-tolerance in the immune system: turning lymphocytes offScience. 1998.

B H Nelson. IL-2, regulatory T cells, and toleranceJ Immunol. 2004.

T Zelante, J Fric, A Y Wong, P Ricciardi-Castagnoli. Interleukin-2 production by dendritic cells and its immuno-regulatory functionsFront Immunol. 2012.

F Granucci, C Vizzardelli, N Pavelka. Inducible IL-2 production by dendritic cells revealed by global gene expression analysisNat Immunol. 2001.

F Granucci, S Feau, V Angeli, F Trottein, P Ricciardi-Castagnoli. Early IL-2 production by mouse dendritic cells is the result of microbial-induced primingJ Immunol. 2003.

D R Green, N Droin, M Pinkoski. Activation-induced cell death in T cellsImmunol Rev. 2003.

P H Krammer, R Arnold, I N Lavrik. Life and death in peripheral T cellsNat Rev Immunol. 2007.

J Dhein, H Walczak, C Baumler, K M Debatin, P H Krammer. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)Nature. 1995.

V Feuillet, B Lucas, Di Santo, J P Bismuth, G Trautmann, A. Multiple survival signals are delivered by dendritic cells to naive CD4 + T cellsEur J Immunol. 2005.

M B Lutz, R M Suri, M Niimi, A L Ogilvie, N A Kukutsch, S Rossner, G Schuler, J M Austyn. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivoEur J Immunol. 2000.

P Yu, S Xiong, Q He, Y Chu, C Lu, C A Ramlogan, J C Steel. Induction of allogeneic mixed chimerism by immature dendritic cells and bone marrow transplantation leads to prolonged tolerance to major histocompatibility complex disparate allograftsImmunology. 2009.

T Fujioka, Y Taniguchi, T Masuda. The effect on the proliferation and apoptosis of alloreactive T cells of cell dose in a murine MHC-mismatched hematopoietic cell transplantation modelTranspl Immunol. 2003.

I Jedema, N M Van Der Werff, R M Barge, R Willemze, J H Falkenburg. New CFSEbased assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell populationBlood. 2004.

D D Taub, J R Ortaldo, S M Turcovski-Corrales, M L Key, D L Longo, W J Murphy. Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine productionJ Leukoc Biol. 1996.

J Geisel, F Kahl, M Muller, H Wagner, C J Kirschning, I B Autenrieth, J S Frick. IL-6 and maturation govern TLR2 and TLR4 induced TLR agonist tolerance and cross-tolerance in dendritic cellsJ Immunol. 2007.

S Rulle, Mda Kioon, C Asensio, J Mussard, H K Ea, M C Boissier, F Liote, G Falgarone. Adrenomedullin, a neuropeptide with immunoregulatory properties induces semimature tolerogenic dendritic cellsImmunology. 2012.

Z Y Wang, H Sato, S Kusam, S Sehra, L M Toney, A L Dent. Regulation of IL-10 gene expression in Th2 cells by Jun proteinsJ Immunol. 2005.

H R Jiang, E Muckersie, M Robertson, H P Xu, J Liversidge, J V Forrester. Secretion of interleukin-10 or interleukin-12 by LPS-activated dendritic cells is critically dependent on time of stimulus relative to initiation of purified DC cultureJ Leukoc Biol. 2002.

D F Fiorentino, M W Bond, T R Mosmann. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clonesJ Exp Med. 1989.

K Taga, G Tosato. IL-10 inhibits human T cell proliferation and IL-2 productionJ Immunol. 1992.

K Taga, J Chretien, B Cherney, L Diaz, M Brown, G Tosato. Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cellsJ Clin Invest. 1994.

F Castellino, A Y Huang, G Altan-Bonnet, S Stoll, C Scheinecker, R N Germain. Chemokines enhance immunity by guiding naive CD8 + T cells to sites of CD4 T cell-dendritic cell interactionNature. 2006.

A Kaiser, E Donnadieu, J P Abastado, A Trautmann, A Nardin. CC chemokine ligand 19 secreted by mature dendritic cells increases naive T cell scanning behavior and their response to rare cognate antigenJ Immunol. 2005.

A W Yewdall, S B Drutman, F Jinwala, K S Bahjat, N Bhardwaj. CD8 + T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cellsPLoS ONE. 2010.

A Martin-Fontecha, S Sebastiani, U E Hopken, M Uguccioni, M Lipp, A Lanzavecchia, F Sallusto. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and primingJ Exp Med. 2003.

N S Wilson, D El-Sukkari, G T Belz, C M Smith, R J Steptoe, W R Heath, K Shortman, J A Villadangos. Most lymphoid organ dendritic cell types are phenotypically and functionally immatureBlood. 2003.

J Park, C Wu, J D Bryers. Chemokine programming dendritic cell antigen response: Part I Select chemokine programming of antigen uptake even after maturationImmunology. 2013.

N Janikashvili, N Larmonier, E Katsanis. Personalized dendritic cell-based tumor immunotherapyImmunotherapy. 2010.

A Sexton, P G Whitney, S F Chong. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsulesACS Nano. 2009.

H P Feng, Y Zeng, M W Graner, A Likhacheva, E Katsanis. Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunityBlood. 2003.

A Zabaleta, D Llopiz, L Arribillaga. Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 proteinMol Ther. 2008.

D Boczkowski, S K Nair, J H Nam, H K Lyerly, E Gilboa. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cellsCancer Res. 2000.

J C Steele, A Rao, J R Marsden. Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanomaGene Ther. 2011.

A Bolhassani, S Safaiyan, S Rafati. Improvement of different vaccine delivery systems for cancer therapyMol Cancer. 2011.

B Weide, C Garbe, H G Rammensee, S Pascolo. Plasmid DNA-and messenger RNAbased anti-cancer vaccinationImmunol Lett. 2008.

Chemokine programming dendritic cell antigen response: part II - programming antigen presentation to T lymphocytes by partially maintaining immature dendritic cell phenotype.